11 – 20 of 30
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Multisystemisk terapi i Sverige : Evidensbaserad metod i nytt sammanhang
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY)
(
- Contribution to journal › Article
- 2010
-
Mark
Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis: update of the EDEN Psoriasis Survey 2001-2006
(
- Contribution to journal › Article
- 2009
-
Mark
The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) Trial: clinical rationale, study design, and implementation
(
- Contribution to journal › Article
- 2008
-
Mark
A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer
(
- Contribution to journal › Article
-
Mark
A randomized trial of basing treatment on human papillomavirus and/or cytology results in low-grade cervical lesion triage
(
- Contribution to journal › Article
-
Mark
The transportability of multisystemic therapy to Sweden: Short-term results from a randomized trial of conduct-disordered youths
(
- Contribution to journal › Article
-
Mark
8-Year follow-up of randomized trial : Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer
(
- Contribution to journal › Article
- 2007
-
Mark
Outcome parameters for trials in atrial fibrillation - Recommendations from a consensus conference organized by the German atrial fibrillation competence NETwork and the European Heart Rhythm Association
(
- Contribution to journal › Scientific review
-
Mark
Outcome parameters for trials in atrial fibrillation: executive summary
(
- Contribution to journal › Scientific review